Neuropathy — damage to the supplemental jitters — affects an estimated 20 million Americans. It causes burning, chinking, impassiveness, and pain that can be enervating. Yet for numerous cases, the standard individual workup comes back inconclusive. Nerve conduction studies( NCS) and electromyography( EMG) show nothing abnormal. Neurologists suggest staying and watching. The case, meanwhile, is left without answers — or worse, dismissed entirely. This individual gap isn’t a failure of the case. It’s a failure of the tools. Standard electrodiagnostic tests measure large, heavily myelinated Fibers. But the nerves most generally damaged in early or small- fiber neuropathy — thin, smoothly myelinated A-delta filaments and unmyelinated C filaments are unnoticeable to these styles. By the time EMG findings become abnormal, significant nerve loss has frequently already passed. TLab has developed a confocal ray microscopy- grounded nerve Injury Imaging test that directly visualizes nerve fiber structure and demyelination in skin bipsy samples. This test gives clinicians a commodity no EMG or NCV study can — a high- resolution image of nerve damage at the tissue position.

Why Conventional Neuropathy Testing Falls Short

To understand why this matters, it helps to understand what conventional tests actually measure:

What Confocal Nerve Injury Imaging Reveals

TLab’s Nerve Injury Imaging test uses a skin biopsy instance — a minimally invasive procedure — combined with high- resolution confocal ray scanning microscopy. This approach produces detailed 3D images of nerve fibre armature at a position of resolution not attainable with conventional light microscopy.

Specifically, the test is designed to visualize:

Who Is This Test For?

TLab’s nerve Injury Imaging test is intended for clinicians assessing cases with neurological symptoms that haven’t been explained by a conventional workup. It’s particularly applicable in the following clinical surrounds

The Connection to Tick-Borne and Inflammatory Disease

TLab has particular expertise in the crossroad of contagious complaint and neurological injury. Research has established that patient Borrelia( Lyme) infection, Bartonella, and related pathogens can cause direct nerve damage through multiple mechanisms, including axonal irruption, perivasculitis of the vasa nervorum, and vulnerable complex deposit. In numerous of these cases, the neuropathy isn’t incidental; it’s a direct manifestation of ongoing infection or post-infectious seditious damage. Standard serological tests constantly miss these infections. Standard neuropathy tests miss the performance of nerve injury. The combination leaves cases in an individual no- man’s land. TLab’s integrated testing approach — combining RNA- grounded molecular imaging for direct pathogen discovery with confocal nerve injury imaging for direct visualization of tissue damage — offers clinicians a more complete picture of what’s actually passing at the pathophysiological position.

How the Test Works: A Simple Overview for Clinicians

The nerve Injury Imaging test requires a skin punch biopsy, generally taken from the distal leg ( shin or ankle) and/ or thigh. The procedure is performed in the clinic using standard punch biopsy fashion. The instance is placed in an applicable fixative and packed to TLab using the hand tackle and instructions. At TLab, the instance undergoes immunofluorescence staining targeting nerve fiber labels, followed by confocal ray scanning microscopy. The performing high- resolution 3D images are anatomised by expert laboratory scientists. The final report includes representative images alongside the logical findings — giving clinicians visual as well as quantitative substantiation to support clinical decision-making. Ordering is straightforward. Physicians and providers with an being TLab account can add the nerve Injury Imaging test to their test importunity. For new accounts, the process of setting up access, carrying importunity forms, and enabling secure results reporting through TLab’s gate is simple and can be initiated by reaching TLab directly.

A Note on the Diagnostic Landscape

Neuropathy is one of the drug’s most underdiagnosed conditions, and small- fiber neuropathy specifically is only beginning to receive the clinical attention it deserves. New exploration continues to establish its frequency in conditions ranging from fibromyalgia and Sjogren’s pattern to post-viral runs and tick- borne infections. The development of high- resolution, image-grounded nerve evaluation tools represents a meaningful advance in this space, moving from circular, functional conclusions to direct tissue-position substantiation.